← Back to Search

Essential Oil

Peppermint oil for Abdominal Pain

Phase 1
Waitlist Available
Led By Robert J Shulman, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial is examining the effects of menthol in children with functional abdominal pain. The first aim is to determine the exposure (how much menthol) vs. response (how the child reacts). The second aim is to see how menthol affects the microbiome and transit rate. The last aim is to see if there is a correlation between the child's symptoms and the menthol.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gut Microbiome composition
Gut contractility
Gut transit time
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 900 mgExperimental Treatment1 Intervention
Peppermint oil at a dose of 180 mg five times daily orally
Group II: 540 mgActive Control1 Intervention
Peppermint oil at a dose of 180 mg thrice daily orally
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peppermint oil
2018
Completed Phase 1
~230

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,252 Total Patients Enrolled
5 Trials studying Abdominal Pain
648 Patients Enrolled for Abdominal Pain
Robert J Shulman, MDPrincipal InvestigatorBaylor College of Medicine
2 Previous Clinical Trials
636 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for participants in this research effort?

"According to the details posted on clinicaltrials.gov, enrollment for this medical study is open and ongoing; it was initially listed on July 9th 2020 and underwent its most recent update on November 11th 2021."

Answered by AI

Has the efficacy of Peppermint oil ever been explored in a clinical setting?

"Currently, 29 clinical trials are studying the effects of Peppermint oil. Of those studies, 5 have reached Phase 3 and 1168 locations across the world are offering this treatment. Notably, most of these sites can be found in Houston Texas."

Answered by AI

For which patients is this clinical trial suitable?

"To meet the criteria for this trial, participants must be between 7 and 12 years of age and suffering from colicky pain. Approximately 42 individuals are being sought for recruitment."

Answered by AI

Is the age limitation for this experiment greater than 25?

"According to the requirements of this clinical trial, children between 7 and 12 years old are eligible. Additionally, 15 patients under 18 and 35 adults over 65 can apply."

Answered by AI

To what ailments does Peppermint oil typically provide relief?

"Peppermint oil is a natural remedy for chilblains, catarrh, and psoriasis."

Answered by AI

How many participants is this clinical study enrolling?

"Yes, clinicaltrials.gov confirms that this medical study is actively recruiting patients. It was initially posted on July 9th 2020 and the most recent update occurred on November 11th 2021. 42 individuals need to be enrolled from a single site for completion of the trial."

Answered by AI

Has the U.S Food & Drug Administration sanctioned Peppermint oil for use?

"Our risk assessment at Power rated Peppermint oil's safety as a 1 due to its current trials being in Phase 1, thereby indicating limited evidence of efficacy and security."

Answered by AI
~0 spots leftby Apr 2025